ISIN | CH0378641150 |
---|---|
Valor Number | 37864115 |
Bloomberg Global ID | |
Fund Name | Swisscanto (CH) Equity Fund Responsible Switzerland CT CHF |
Fund Provider |
Swisscanto Fondsleitung AG
Zurich E-Mail: fonds@swisscanto.ch |
Fund Provider | Swisscanto Fondsleitung AG |
Representative in Switzerland | |
Distributor(s) | Schweizerische Kantonalbanken |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Switzerland |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | The Fund offers the investor an opportunity to participate in companies of the Swiss Performance Index (SPI). The fund is targeted at investors who are looking for capital gains and have a long investment horizon that allows for the volatile nature of equity investments. The security selection benefits from the stock picking recommendations made by the financial analysts of the Fund. |
Peculiarities |
Current Price * | 140.60 CHF | 02.10.2025 |
---|---|---|
Previous Price * | 139.61 CHF | 01.10.2025 |
52 Week High * | 145.02 CHF | 03.03.2025 |
52 Week Low * | 122.48 CHF | 09.04.2025 |
NAV * | 140.60 CHF | 02.10.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 818,037,760 | |
Unit/Share Assets *** | 77,049,145 | |
Trading Information SIX |
YTD Performance | +8.23% |
31.12.2024 - 02.10.2025
31.12.2024 02.10.2025 |
---|---|---|
1 month | +1.32% |
02.09.2025 - 02.10.2025
02.09.2025 02.10.2025 |
3 months | +1.55% |
02.07.2025 - 02.10.2025
02.07.2025 02.10.2025 |
6 months | +0.35% |
02.04.2025 - 02.10.2025
02.04.2025 02.10.2025 |
1 year | +3.64% |
02.10.2024 - 02.10.2025
02.10.2024 02.10.2025 |
2 years | +15.43% |
02.10.2023 - 02.10.2025
02.10.2023 02.10.2025 |
3 years | +21.95% |
03.10.2022 - 02.10.2025
03.10.2022 02.10.2025 |
5 years | +24.44% |
02.10.2020 - 02.10.2025
02.10.2020 02.10.2025 |
Equity Participation Rate in % | 92.87 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | 0.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Roche Holding AG | 11.60% | |
---|---|---|
Nestle SA | 10.54% | |
Novartis AG Registered Shares | 9.92% | |
UBS Group AG Registered Shares | 6.34% | |
Zurich Insurance Group AG | 5.11% | |
ABB Ltd | 4.86% | |
Lonza Group Ltd | 4.17% | |
Compagnie Financiere Richemont SA Class A | 3.91% | |
Swiss Re AG | 3.47% | |
Givaudan SA | 2.92% | |
Last data update | 31.08.2025 |
TER | 0.74% |
---|---|
TER date | 30.09.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 1.05% |
Ongoing Charges *** | 0.74% |
SRRI ***
|
|
SRRI date *** | 31.08.2025 |